Patents by Inventor Hanna Lindberg

Hanna Lindberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210355180
    Abstract: The present disclosure relates to a class of engineered polypeptides having a binding affinity for amyloid ? (A?) peptides (in the following referred to as A?), comprising the amino acid sequence EX2X3YX5X6NLX9A X11QLCAX16IX18X19X20 ED (SEQ ID NO:632). The present disclosure also relates to the use of such A? peptide binding polypeptides as therapeutic, prognostic and/or diagnostic agents.
    Type: Application
    Filed: July 22, 2021
    Publication date: November 18, 2021
    Inventors: Stefan Ståhl, John Löfblom, Hanna Lindberg, Torleif Härd
  • Patent number: 11098096
    Abstract: The present disclosure relates to a class of engineered polypeptides having a binding affinity for amyloid ? (A?) peptides (in the following referred to as A?), comprising the amino acid sequence EX2X3YX5X6NLX9A X11QLCAX16IX18X19X20 ED (SEQ ID NO:632). The present disclosure also relates to the use of such A? peptide binding polypeptides as therapeutic, prognostic and/or diagnostic agents.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: August 24, 2021
    Assignee: AMYLONIX AB
    Inventors: Stefan Ståhl, John Löfblom, Hanna Lindberg, Torleif Härd
  • Publication number: 20200172588
    Abstract: The present disclosure relates to a class of engineered polypeptides having a binding affinity for amyloid ? (A?) peptides (in the following referred to as A?), comprising the amino acid sequence EX2X3YX5X6NLX9A X11QLCAX16IX18X19X20 ED (SEQ ID NO:632). The present disclosure also relates to the use of such A? peptide binding polypeptides as therapeutic, prognostic and/or diagnostic agents.
    Type: Application
    Filed: December 16, 2019
    Publication date: June 4, 2020
    Inventors: Stefan Ståhl, John Löfblom, Hanna Lindberg, Torleif Härd
  • Publication number: 20180057551
    Abstract: The present disclosure relates to a class of engineered polypeptides having a binding affinity for amyloid ? (A?) peptides (in the following referred to as A?), comprising the amino acid sequence EX2X3YX5X6NLX9AX11QLCAX16IX18X19X20 ED. The present disclosure also relates to the use of such A? peptide binding polypeptides as therapeutic, prognostic and/or diagnostic agents.
    Type: Application
    Filed: February 22, 2016
    Publication date: March 1, 2018
    Inventors: Stefan Ståhl, John Löfblom, Hanna Lindberg, Torleif Härd